Female reproductive history in relation to chronic obstructive pulmonary disease and lung function in UK biobank: a prospective population-based cohort study. Issue 10 (28th October 2019)

• Record Type: Journal Article
• Authors: Tang, Rosalind; Fraser, Abigail; Magnus, Maria Christine
• Is Part Of: BMJ open. Volume 9:Issue 10(2019)
• Publication Date: 2019-10-28
• Subjects: chronic obstructive pulmonary disease -- spirometry -- menarche -- menopause -- oral contraceptives -- hormone replacement therapy; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2019-030318
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: Sex differences in respiratory physiology and predilection for developing chronic obstructive pulmonary disease (COPD) have been documented, suggesting that female sex hormones may influence pathogenesis. We investigated whether aspects of female reproductive health might play a role in risk of COPD among women. Design: Population-based prospective cohort study. Setting: UK Biobank recruited across 22 centres in the UK between 2006 to 2010. Primary and secondary outcomes measures: We examined a range of female reproductive health indicators in relation to risk of COPD-related hospitalisation/death (n=271 271) using Cox proportional hazards regression; and lung function (n=273 441) using linear regression. Results: Parity >3 was associated with greater risk of COPD-related hospitalisation/death (adjusted HR 1.45; 95% CI: 1.16 to 1.82) and lower forced expiratory volume at 1 second/forced vital capacity ratio (FEV1 /FVC) (adjusted mean difference −0.06; 95% CI: -0.07 to 0.04). Any oral contraception use was associated with lower risk of COPD-related hospitalisation/death (adjusted HR 0.85; 95% CI: 0.74 to 0.97) and greater FEV1 /FVC (adjusted mean difference 0.01; 95% CI: 0.003 to 0.03). Late menarche (age >15) and early menopause (age <47) were also associated with greater risk of COPD-related hospitalisation/death (but not lung function), while endometriosis was associated with greater FEV1 /FVC (not COPD-related hospitalisation/death). Early menarche (age <12 years) was associated with lower FEV1 /FVC (but not COPD hospitalisation/death). Associations with polycystic ovary syndrome (PCOS) or ovarian cysts, any hormone replacement therapy (HRT) use, hysterectomy-alone and both hysterectomy and bilateral oophorectomy were in opposing directions for COPD-related hospitalisation/death (greater risk) and FEV1 /FVC (positive association). Conclusions: Multiple female reproductive health indicators across the life course are associated with COPD-related hospitalisation/death and lung function. Further studies are necessary to understand the opposing associations of PCOS/ovarian cysts, HRT and hysterectomy with COPD and objective measures of airway obstruction.